Skip to main content

Table 6 Clinical features of 261 CHC patients from Northern Italy according to the PNPLA3 I148M genotype

From: The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

PNPLA3genotype

CC n = 133 (51)

CG n = 103 (39)

GG n = 25 (10)

p value

Age (years)

57±14

59±14

57±14

0.47

Sex (F)

58 (44)

46 (45)

6 (24)

0.16

BMI (Kg/m2)

25.2±3.4

25.3±3.9

26.6±6.1

0.25

ALT (IU/ml)

72±56

67±58

73±78

0.81

Diabetes

26 (20)

17 (17)

4 (16)

0.80

Insulin (IU/ml)

21 {14–27}

20 {17–27}

17 {12–25}

0.61

Glucose

95±22

96±26

93±22

0.85

Total cholesterol (mg/dl)

176±36

177±41

178±41

0.95

HDL cholesterol (mg/dl)

50±15

51±18

48±15

0.66

Triglycerides (mg/dl)

108±43

104±61

88±31*

0.24

HOMA-IR

4.7 {3.2-5.8}

4.5 {3.4-6.6}

3.8 {2.3-6.5}

0.62

Adiponectin (μg/ml)

9.3 {5.8-13}

9.4 {5.7-14}

9.7 {5.3-13}

0.93

Steatosis

85 (64)

72 (70)

22 (88)

0.02

Severe steatosis (> 33%)

8 (6)

7 (7)

8 (32)

<0.0001

Cirrhosis

34 (26)

36 (35)

10 (40)

0.06

  1. ():% values; {}: interquartile range, reported with median value; *p < 0.05 vs. other genotypes.